Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bendamustine in relapsed or refractory T-cell lymphoma
2009-010017-72Phase 2Active
- Sponsor
- Goelams
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bendamustine in non-Hodgkin lymphoma, T-cell and lymphosarcoma, sponsored by Goelams. Primary endpoint: Overall response rate. Started Apr 2009; status: active.
02
Drugs
bendamustine
03
Conditions
non-Hodgkin lymphoma, T-celllymphosarcoma
Beyond the preview
Go deeper on 2009-010017-72.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010017-72.